Chicken Blood Bacteria: Understanding Avian Pathogenic Escherichia coli (APEC) and Colibacillosis

Introduction

Avian Pathogenic Escherichia coli (APEC) represents a distinct pathotype of extraintestinal pathogenic E. coli (ExPEC) responsible for colibacillosis, a complex and economically devastating disease syndrome in poultry [1, 2]. Colibacillosis manifests as a systemic infection characterized by fibrinous lesions in multiple organs, including airsacculitis, pericarditis, perihepatitis, and septicemia [1, 3]. The presence of APEC in chicken blood, termed bacteremia, is a hallmark of systemic dissemination and a critical juncture in disease progression [4, 5]. Unlike commensal E. coli strains residing in the avian gastrointestinal tract, APEC strains possess a suite of specialized virulence factors that enable them to colonize extraintestinal sites, evade host immune defenses, and cause severe pathology [6, 2]. Understanding the molecular mechanisms of APEC pathogenesis, the host-pathogen interactions within the bloodstream, and the diagnostic approaches for detecting bacteremia is essential for effective disease management and control in commercial poultry operations [1, 2].

Etiology and Classification of APEC

APEC strains belong to the species Escherichia coli, a Gram-negative, facultative anaerobic bacillus of the family Enterobacteriaceae [1]. Unlike enteric pathogenic E. coli, APEC is classified as an extraintestinal pathogen [1, 2]. Serotyping based on O (somatic), H (flagellar), and K (capsular) antigens has historically been used to classify APEC isolates, with serogroups O1, O2, and O78 being among the most frequently associated with colibacillosis outbreaks globally [1, 2]. However, APEC strains exhibit considerable genetic diversity, and no single serogroup defines the pathotype [1]. Molecular typing methods, including multilocus sequence typing (MLST), have revealed that APEC isolates belong to multiple sequence types (STs), with ST95 and ST131 being prominent lineages that also share genetic similarities with human uropathogenic E. coli (UPEC) and neonatal meningitis E. coli (NMEC) [2]. This genetic overlap raises concerns about the zoonotic potential of APEC, as certain strains may be capable of causing disease in humans [2].

Virulence Factors and Pathogenesis

The pathogenicity of APEC is multifactorial, relying on a coordinated arsenal of virulence determinants that facilitate each step of the infection process [1, 2]. These factors can be broadly categorized into adhesins, invasins, iron acquisition systems, protectins (including capsule and lipopolysaccharide), and toxins [1, 2]. The expression of these virulence genes is tightly regulated by quorum sensing systems, two-component regulatory systems, and transcriptional regulators [7, 2].

Adhesins and Colonization

Initial colonization of the respiratory tract, often the primary portal of entry, is mediated by fimbrial adhesins such as type 1 fimbriae (FimH), P fimbriae (PapG), and curli fibers [1, 2]. These structures bind to specific receptors on host epithelial cells, enabling the bacteria to resist mechanical clearance [1]. Biofilm formation, a process involving curli and cellulose production, further enhances persistence on mucosal surfaces and environmental surfaces [8]. Genotypic characterization of biofilm-producing APEC isolates has demonstrated associations between biofilm formation capacity and the presence of specific virulence genes, as well as antimicrobial resistance profiles [8].

Iron Acquisition Systems

Iron is an essential micronutrient for bacterial growth, and its bioavailability within the avian host is severely limited by iron-binding proteins such as transferrin and lactoferrin [1]. APEC strains overcome this limitation through the production of siderophores, including aerobactin and salmochelin, which have a higher affinity for iron than host proteins [1, 2]. The genes encoding these siderophore systems (e.g., iucABCD, iroN) are frequently located on large virulence plasmids, such as the ColV or ColBM plasmids, which are characteristic of many APEC strains [6, 2]. The phosphate-specific transport (Pst) system also plays a role in virulence; inactivation of the pst system has been shown to reduce the virulence of an APEC O78 strain, highlighting the importance of phosphate homeostasis in pathogenesis [9].

Toxins and Tissue Damage

APEC strains produce several toxins that contribute to tissue damage and immune evasion. Hemolysins, such as the enterohemolysin (EhxA), can lyse erythrocytes and other host cells, releasing nutrients and facilitating bacterial spread [1]. The vacuolating autotransporter toxin (Vat) and the cytotoxin necrotizing factor 1 (CNF1) are also associated with APEC virulence [2]. These toxins disrupt host cell signaling and cytoskeletal architecture, leading to cell death and inflammation [2].

Serum Resistance and Immune Evasion

Once APEC enters the bloodstream, it must resist the bactericidal effects of complement and phagocytes [10]. The polysaccharide capsule (K antigen) and the lipopolysaccharide (LPS) O-antigen provide protection against complement-mediated lysis [1]. The outer membrane protease OmpT and the increased serum survival protein (Iss) are additional factors that contribute to serum resistance [2]. Transcriptomic analyses have shown that APEC infection induces a robust inflammatory response in the host, characterized by the upregulation of genes involved in innate immunity, cytokine signaling, and cell death pathways [11, 12, 5]. The host response in peripheral blood leukocytes has been shown to strongly correlate with transcriptomic patterns in the spleen, indicating that blood leukocytes are a relevant and accessible tissue for studying systemic immune responses to APEC [4].

Pathophysiology of Colibacillosis

Colibacillosis typically begins with the inhalation or ingestion of APEC from a contaminated environment [1, 3]. The bacteria initially colonize the upper respiratory tract, particularly the trachea and air sacs [3]. Under favorable conditions, such as immunosuppression from concurrent viral infections (e.g., infectious bronchitis virus, infectious bursal disease virus) or environmental stress, APEC proliferates and invades the deeper respiratory tissues [13, 1]. The bacteria then enter the bloodstream, resulting in bacteremia [4, 5]. From the blood, APEC disseminates to internal organs, including the liver, spleen, heart, and pericardium [1, 3]. The host inflammatory response leads to the deposition of fibrin, resulting in the characteristic fibrinous lesions of perihepatitis, pericarditis, and airsacculitis [1, 3]. In severe cases, septicemia and endotoxic shock can lead to rapid death [1].

Experimental infection models have been developed to study the pathophysiology of colibacillosis. A comparative study of intratracheal and subcutaneous infection routes in broilers found that the intratracheal route produces clinical signs and pathogenesis more similar to natural field conditions, including prominent lung injuries and airsacculitis [3]. In contrast, the subcutaneous route resulted in more severe disease, with cellulitis and severe kidney injuries, but did not replicate the respiratory portal of entry [3]. The Galleria mellonella larvae model has also been validated as an alternative in vivo system for assessing APEC pathogenicity, offering a high-throughput and ethically favorable screening tool [14].

Host Immune Response

The chicken immune system mounts a complex response to APEC infection, involving both innate and adaptive components [15]. The innate response is initiated by pattern recognition receptors (PRRs) that detect pathogen-associated molecular patterns (PAMPs) such as LPS, flagellin, and CpG DNA [15]. This recognition triggers the production of pro-inflammatory cytokines (e.g., IL-1β, IL-6, IL-8) and chemokines, which recruit heterophils and macrophages to the site of infection [11, 12]. Transcriptomic studies have revealed that APEC infection induces the expression of genes associated with inflammation and cell death programs, including those involved in apoptosis and necroptosis [11]. The combined analysis of primary lymphoid tissues (bursa of Fabricius and thymus) has shown that APEC infection modulates the expression of genes related to B cell and T cell development, potentially impacting adaptive immunity [12].

The adaptive immune response involves the production of specific antibodies against APEC surface antigens, including LPS and outer membrane proteins [16, 13]. Opsonizing antibodies enhance phagocytosis and bacterial clearance [13]. However, the efficacy of the humoral response can be suppressed by concurrent viral infections, such as infectious bursal disease virus, which compromises B cell function [13]. Vaccination strategies aim to induce robust and protective adaptive immunity, but the diversity of APEC serotypes and the lack of cross-protection remain significant challenges [16, 1, 2].

Diagnosis of APEC and Colibacillosis

Diagnosis of colibacillosis is based on a combination of clinical signs, gross pathology, histopathology, and bacteriological culture [17, 1]. Definitive diagnosis requires the isolation and identification of E. coli from the blood or internal organs of affected birds, ideally from lesions characteristic of colibacillosis [17, 1].

Clinical and Pathological Examination

Clinical signs of colibacillosis are non-specific and may include depression, ruffled feathers, reduced feed intake, respiratory distress, and increased mortality [1, 3]. At necropsy, characteristic fibrinous lesions are observed on the pericardium (pericarditis), liver capsule (perihepatitis), and air sacs (airsacculitis) [1, 3]. Histopathological examination reveals fibrin deposition, heterophil infiltration, and necrosis [17].

Bacteriological Culture

Samples for culture should be collected aseptically from the heart blood, liver, spleen, or bone marrow [17, 3]. Samples are plated on selective media such as MacConkey agar or eosin methylene blue (EMB) agar and incubated aerobically at 37°C for 18-24 hours [17]. Lactose-fermenting colonies are presumptively identified as E. coli and confirmed by biochemical tests (e.g., indole production, methyl red, Voges-Proskauer, citrate utilization) or by using commercial identification systems [17].

Molecular Diagnostics

Molecular methods, particularly polymerase chain reaction (PCR), are widely used for the detection and characterization of APEC [17, 6, 18, 8]. PCR assays targeting specific virulence genes (e.g., iroN, iss, iucD, tsh, vat) can differentiate APEC from commensal E. coli strains [17, 6, 2]. Multiplex PCR panels allow for the simultaneous detection of multiple virulence markers, providing a rapid and sensitive diagnostic tool [6, 18]. DNA microarray technology has also been employed for high-throughput transcriptional profiling of APEC during infection, revealing the coordinated expression of virulence and metabolic genes [19]. Genotypic characterization of antimicrobial resistance genes is increasingly important for surveillance and treatment guidance [18, 8].

Serology

Serological tests, such as enzyme-linked immunosorbent assays (ELISA), can detect antibodies against APEC antigens in serum or egg yolk [16]. While serology is useful for monitoring flock exposure and vaccine responses, it is not typically used for diagnosing acute clinical disease due to the lag time between infection and antibody production [16].

Treatment and Control

Antimicrobial Therapy

Treatment of colibacillosis traditionally relies on the administration of antimicrobial agents, such as florfenicol, enrofloxacin, or amoxicillin [3]. However, the emergence and spread of antimicrobial resistance (AMR) among APEC isolates is a major concern [18, 2, 8]. Resistance to multiple antibiotic classes, including critically important drugs like carbapenems, has been reported [2]. Phenotypic resistance profiling, often performed using disk diffusion or broth microdilution methods, is essential for guiding effective therapy [18]. The high prevalence of AMR genes in APEC populations underscores the need for prudent antimicrobial use and the development of alternative control strategies [2, 8].

Vaccination

Vaccination is a key component of colibacillosis control programs [16, 1, 2]. Both inactivated (bacterin) and live attenuated vaccines have been developed [16, 1]. Autogenous vaccines, prepared from specific farm isolates, are sometimes used to address local serotype diversity [1]. Spray vaccination with live E. coli vaccines has been shown to induce mucosal immunity and reduce clinical signs [16]. However, commercially available vaccines often provide limited cross-protection against heterologous APEC serotypes, and the development of broadly protective vaccines remains an active area of research [1, 2].

Alternative Control Strategies

Given the limitations of antimicrobials and current vaccines, alternative strategies are being investigated [7, 1, 2]. Quorum sensing inhibitors (QSIs) that target the auto-inducer 2 (AI-2) signaling system have shown promise in reducing APEC virulence and biofilm formation in experimental settings [7]. Other approaches include the use of bacteriophages, probiotics, prebiotics, and organic acids to modulate the gut microbiota and inhibit APEC colonization [1, 2]. Improved biosecurity, management practices, and environmental control (e.g., litter management, ventilation) are also critical for reducing the incidence of colibacillosis [1].

Conclusion

Avian pathogenic Escherichia coli remains a formidable pathogen in the poultry industry, causing significant economic losses through colibacillosis [1, 2]. The pathogenesis of APEC is a complex interplay of bacterial virulence factors and host immune responses, with bacteremia serving as a critical step in systemic dissemination [4, 5]. Accurate diagnosis relies on a combination of pathological examination, bacterial culture, and molecular characterization of virulence and resistance genes [17, 18, 8]. Effective control requires an integrated approach that includes biosecurity, vaccination, and the judicious use of antimicrobials, alongside the development of novel therapeutic strategies such as quorum sensing inhibitors [7, 1, 2]. Continued research into the molecular mechanisms of APEC pathogenesis and host immunity is essential for the development of more effective and sustainable control measures.

References

[1] Khairullah A, Afnani DA, Riwu KHP et al. Avian pathogenic Escherichia coli: Epidemiology, virulence and pathogenesis, diagnosis, pathophysiology, transmission, vaccination, and control. Veterinary World. 2024. URL: https://www.semanticscholar.org/paper/daaba66dacad27cf1c125689d5d9f6337e615891

[2] Kathayat D, Lokesh D, Ranjit S et al. Avian Pathogenic Escherichia coli (APEC): An Overview of Virulence and Pathogenesis Factors, Zoonotic Potential, and Control Strategies. Pathogens. 2021. URL: https://www.semanticscholar.org/paper/35246d12abeb44e1e0e7dc52634dbe3a3b86535e

[3] Saberi A, Mosleh N, Shomali T et al. A Comparative Study on Two Infection Models of Colibacillosis in Broilers: Clinical Features, Pathogenesis, and Response to Therapy. Avian Dis. 2023. URL: https://www.semanticscholar.org/paper/56d41097aea04b03373eb2eeba0a098f7980171a

[4] Sandford EE, Orr M, Li X et al. Strong concordance between transcriptomic patterns of spleen and peripheral blood leukocytes in response to avian pathogenic Escherichia coli infection. Avian Dis. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/23397846/

[5] Sandford EE, Orr M, Shelby M et al. Leukocyte transcriptome from chickens infected with avian pathogenic Escherichia coli identifies pathways associated with resistance. Results Immunol. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/24371566/

[6] Wu G, Ehricht R, Mafura M et al. Escherichia coli isolates from extraintestinal organs of livestock animals harbour diverse virulence genes and belong to multiple genetic lineages. Vet Microbiol. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22766078/

[7] Helmy YA, Kathayat D, Deblais L et al. Evaluation of Novel Quorum Sensing Inhibitors Targeting Auto-Inducer 2 (AI-2) for the Control of Avian Pathogenic Escherichia coli Infections in Chickens. Microbiol Spectr. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35583333/

[8] Saci S, Houali K, Schena R et al. Phenotypic and genotypic characterization of biofilm-producing avian pathogenic Escherichia coli (APEC) isolates from Algerian poultry: associations between antimicrobial resistance and virulence genes. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40542899/

[9] Lamarche MG, Dozois CM, Daigle F et al. Inactivation of the pst system reduces the virulence of an avian pathogenic Escherichia coli O78 strain. Infect Immun. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/15972503/

[10] Li G, Cai W, Hussein A et al. Proteome response of an extraintestinal pathogenic Escherichia coli strain with zoonotic potential to human and chicken sera. J Proteomics. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22677113/

[11] Mehaisen GM, Eshak MG, El Sabry MI et al. Expression of Inflammatory and Cell Death Program Genes and Comet DNA Damage Assay Induced by Escherichia coli in Layer Hens. PLoS One. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27347679/

[12] Sun H, Bi R, Liu P et al. Combined analysis of primary lymphoid tissues' transcriptomic response to extra-intestinal Escherichia coli (ExPEC) infection. Dev Comp Immunol. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/26710679/

[13] Naqi S, Thompson G, Bauman B et al. The exacerbating effect of infectious bronchitis virus infection on the infectious bursal disease virus-induced suppression of opsonization by Escherichia coil antibody in chickens. Avian Dis. 2001. URL: https://pubmed.ncbi.nlm.nih.gov/11332499/

[14] Camilotti E, Furian TQ, Borges KA et al. Galleria mellonella larvae as an alternative model to determine the pathogenicity of avian pathogenic Escherichia coli. Avian Pathol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38845537/

[15] Wigley P. Immunity to bacterial infection in the chicken. Dev Comp Immunol. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23648643/

[16] Fernandes Filho T, Fávaro C Jr, Ingberman M et al. Effect of spray Escherichia coli vaccine on the immunity of poultry. Avian Dis. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/24283136/

[17] Freshinta JW, Adhitya YRC, Arief M et al. Histopathological Diagnosis and Detection of Avian Pathogenic Escherichia Coli Virulence Genes in Broiler Chickens in Indonesia. Arch Razi Inst. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41769293/

[18] Nedbalcova K, Bzdil J, Papouskova A et al. Pathotypes and Phenotypic Resistance to Antimicrobials of Escherichia coli Isolates from One-Day-Old Chickens. Pathogens. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/38003794/

[19] Gao Q, Xia L, Liu J et al. DNA microarray-mediated transcriptional profiling of avian pathogenic Escherichia coli O2 strain E058 during its infection of chicken. Microb Pathog. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27569534/

[20] Soster P, Grzywalski T, Carvalho CL et al. AI-based monitoring of broiler vocal repertoire dynamics reveals robust developmental and diurnal patterns but limited disease sensitivity. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41933532/

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.